---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-036342"
form_type: "8-K"
ticker: "YCBD"
cik: "0001644903"
company_name: "cbdMD, Inc."
filed_at: "2025-11-25T23:59:59+00:00"
generated_at: "2026-05-16T16:56:19.041534+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# cbdMD Q4 net sales up 3-5% YoY; FY net loss improves to ~$2M from $3.7M

## Summary
- Net sales for fiscal 2025 expected $19.1–19.3M vs $19.5M prior year.
- Q4 net sales expected $4.7–4.9M, up 3-5% from $4.6M in Q4 2024.
- Net loss for fiscal 2025 improved to $1.9–2.1M from $3.7M in fiscal 2024.
- CEO cites disciplined cost management and positive sequential revenue growth.
- Full earnings call scheduled for mid-December 2025.

## SEC filing metadata
- accession: 0001437749-25-036342
- form_type: 8-K
- ticker: YCBD
- cik: 0001644903
- company_name: cbdMD, Inc.
- filed_at: 2025-11-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1644903/000143774925036342/0001437749-25-036342-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1644903/000143774925036342/ycbd20251120_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-036342
- JSON: https://secwatch.observer/filing/0001437749-25-036342.json
- Plain text: https://secwatch.observer/filing/0001437749-25-036342.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.